Corvus Pharmaceuticals
Develops immune-disease and cancer therapies centered on soquelitinib.
$14.16
After-hours close+0.02 (+0.11%)
At close$14.15(−3.91%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.21 | — | — |
| Aug 2026 | −$0.16 | −$0.19 | −19.4% |
| May 2026 | −$0.14 | −$0.15 | −7.1% |
| Mar 2026 | −$0.14 | −$0.15 | −7.1% |
| Nov 2025 | −$0.14 | −$0.12 | +14.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Apr 2021 | |||
| Mar 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Mar 2020 | |||
| Oct 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | −$0.21 | — | — | — | — | — |
| Aug 6, 2026 | −$0.16 | −$0.19 | −19.4% | — | — | — |
| May 7, 2026 | −$0.14 | −$0.15 | −7.1% | — | — | — |
| Mar 12, 2026 | −$0.14 | −$0.15 | −7.1% | $775.0K | — | — |
| Nov 4, 2025 | −$0.14 | −$0.12 | +14.3% | — | — | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 8, 2025 | ||||||
| Mar 25, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 6, 2024 | ||||||
| Mar 19, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 8, 2023 | ||||||
| Mar 28, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 5, 2022 | ||||||
| Mar 10, 2022 | ||||||
| Nov 1, 2021 | ||||||
| Aug 2, 2021 | ||||||
| Apr 29, 2021 | ||||||
| Mar 25, 2021 | ||||||
| Oct 29, 2020 | ||||||
| Jul 30, 2020 | ||||||
| Apr 30, 2020 | ||||||
| Mar 5, 2020 | ||||||
| Oct 29, 2019 | ||||||
| Aug 1, 2019 | ||||||
| May 9, 2019 | ||||||
| Mar 7, 2019 | ||||||
| Nov 1, 2018 | ||||||
| Aug 2, 2018 | ||||||
| May 3, 2018 | ||||||
| Mar 1, 2018 | ||||||
| Nov 2, 2017 | ||||||
| Aug 3, 2017 | ||||||
| May 4, 2017 | ||||||
| Mar 10, 2017 | ||||||
| Nov 3, 2016 | ||||||
| Aug 4, 2016 | ||||||
| May 6, 2016 | ||||||
| Mar 22, 2016 | ||||||
| Dec 31, 2015 | ||||||
| Jun 30, 2015 | ||||||